These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7484490)

  • 21. Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation.
    Zoble RG; Brewington J; Olukotun AY; Gore R
    Am J Cardiol; 1987 Aug; 60(6):39D-45D. PubMed ID: 3307366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo.
    Jordaens L; Trouerbach J; Calle P; Tavernier R; Derycke E; Vertongen P; Bergez B; Vandekerckhove Y
    Eur Heart J; 1997 Apr; 18(4):643-8. PubMed ID: 9129896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting the clinical response to treatment with digoxin and two calcium antagonists in patients with atrial fibrillation.
    Lewis RV; McDevitt DG
    Br J Clin Pharmacol; 1988 May; 25(5):603-6. PubMed ID: 3044426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias].
    Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
    J Cardiol; 1990; 20(3):755-65. PubMed ID: 2151866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness of diltiazem in controlling ventricular response and improving exercise capacity in chronic atrial fibrillation. Double-blind, cross-over study].
    Vitale P; Auricchio A; De Stefano R; Agretto A; De Simone R; Vitale N; Barbato F; Iacono A
    Cardiologia; 1989 Jan; 34(1):73-81. PubMed ID: 2720716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
    DiBianco R; Morganroth J; Freitag JA; Ronan JA; Lindgren KM; Donohue DJ; Larca LJ; Chadda KD; Olukotun AY
    Am Heart J; 1984 Oct; 108(4 Pt 2):1121-7. PubMed ID: 6148872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation.
    Pomfret SM; Beasley CR; Challenor V; Holgate ST
    Clin Sci (Lond); 1988 Apr; 74(4):351-7. PubMed ID: 3281786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ischaemic left ventricular failure: evidence of sustained benefit after 18 months' treatment with xamoterol.
    Vigholt-Sørensen E; Faergeman O
    Br Heart J; 1990 Sep; 64(3):186-9. PubMed ID: 1976339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of clinical experience with xamoterol. Effects on exercise capacity and symptoms in heart failure.
    Marlow HF
    Circulation; 1990 Feb; 81(2 Suppl):III93-8. PubMed ID: 1967561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group.
    Eur Heart J; 1997 Apr; 18(4):649-54. PubMed ID: 9129897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of labetalol in chronic atrial fibrillation.
    Wong CK; Lau CP; Leung WH; Cheng CH
    Am J Cardiol; 1990 Nov; 66(17):1212-5. PubMed ID: 2239725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of beta receptor antagonists in patients with clinical evidence of heart failure after myocardial infarction: double blind comparison of metoprolol and xamoterol.
    Persson H; Rythe'n-Alder E; Melcher A; Erhardt L
    Br Heart J; 1995 Aug; 74(2):140-8. PubMed ID: 7546992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of digitalis glycosides in atrial fibrillation].
    Knez A; Haberl R; Steinbeck G
    Z Kardiol; 1994; 83 Suppl 5():71-3. PubMed ID: 7846948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary study of the efficacy of xamoterol in bradycardia-tachycardia syndrome.
    Mizutani N; Kobayashi T; Watanabe T
    Br J Clin Pharmacol; 1994 Sep; 38(3):285-7. PubMed ID: 7826834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of verapamil and digoxin in the treatment of atrial fibrillation.
    Lewis R; Lakhani M; Moreland TA; McDevitt DG
    Eur Heart J; 1987 Feb; 8(2):148-53. PubMed ID: 3552680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with digoxin and diltiazem controls ventricular rate in chronic atrial fibrillation in dogs better than digoxin or diltiazem monotherapy: a randomized crossover study in 18 dogs.
    Gelzer AR; Kraus MS; Rishniw M; Moïse NS; Pariaut R; Jesty SA; Hemsley SA
    J Vet Intern Med; 2009; 23(3):499-508. PubMed ID: 19645836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low- and medium-dose diltiazem in chronic atrial fibrillation: comparison with digoxin and correlation with drug plasma levels.
    Maragno I; Santostasi G; Gaion RM; Trento M; Grion AM; Miraglia G; Dalla Volta S
    Am Heart J; 1988 Aug; 116(2 Pt 1):385-92. PubMed ID: 3400564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral xamoterol in patients with sinoatrial disease.
    Tseu FL; Morley CA; Mackintosh AF
    Br Heart J; 1986 Nov; 56(5):469-72. PubMed ID: 2878676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xamoterol versus digoxin in heart failure.
    Lancet; 1988 Apr; 1(8590):877. PubMed ID: 2895376
    [No Abstract]   [Full Text] [Related]  

  • 40. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation.
    Lang R; Klein HO; Weiss E; David D; Sareli P; Levy A; Guerrero J; Di Segni E; Kaplinsky E
    Chest; 1983 Mar; 83(3):491-9. PubMed ID: 6337787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.